Gau JP - Search Results

1

Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.

Ko PS, Yu YB, Liu YC, Wu YT, Hung MH, Gau JP, Liu CJ, Hsiao LT, Chen PM, Chiou TJ, Liu CY, Liu JH. Ko PS, et al. Among authors: gau jp. Curr Med Res Opin. 2017 Oct;33(10):1737-1744. doi: 10.1080/03007995.2017.1356708. Epub 2017 Aug 11. Curr Med Res Opin. 2017. PMID: 28715941

2

A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.

Wang FD, Liu CY, Hsu HC, Gau JP, Chau WK, Haung ML, Ho CH. Wang FD, et al. Among authors: gau jp. Chemotherapy. 1999 Sep-Oct;45(5):370-9. doi: 10.1159/000007228. Chemotherapy. 1999. PMID: 10473925 Clinical Trial.

3

Donor lymphocyte infusion induced acute hepatitis.

You JY, Yu YB, Chen PC, Tsay SH, Chen CC, Ho CH, Chau WK, Hsu HC, Gau JP, Tzeng CH. You JY, et al. Among authors: gau jp. J Chin Med Assoc. 2004 Aug;67(8):411-5. J Chin Med Assoc. 2004. PMID: 15553801

4

Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia.

Liu JH, Yen CC, Lin YC, Gau JP, Yang MH, Chao TC, Hsiao LT, Wang WS, Tsai YC, Chen PM. Liu JH, et al. Among authors: gau jp. Leuk Lymphoma. 2004 Dec;45(12):2419-25. doi: 10.1080/10428190400003317. Leuk Lymphoma. 2004. PMID: 15621754

5

Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.

Chen CC, Lee KD, Gau JP, Yu YB, You JY, Lee SC, Hsu HC, Chau WK, Ho CH. Chen CC, et al. Among authors: gau jp. Ann Hematol. 2005 Oct;84(10):675-80. doi: 10.1007/s00277-005-1079-4. Epub 2005 Jul 9. Ann Hematol. 2005. PMID: 16007424

6

Influence of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, B vitamins and other factors on plasma homocysteine and risk of thromboembolic disease in Chinese.

Ho CH, Kuo BI, Kong CW, Chau WK, Hsu HC, Gau JP, Yu YB. Ho CH, et al. Among authors: gau jp. J Chin Med Assoc. 2005 Dec;68(12):560-5. doi: 10.1016/S1726-4901(09)70094-2. J Chin Med Assoc. 2005. PMID: 16379339 Free article.

7

Nucleotide changes around the splicing acceptor of intron 24 in the factor VIII gene and its impact on splicing.

Gau JP, Chen CC, Hsu HC, Ho CH, Chau WK, You JY, Yu YB. Gau JP, et al. Blood Coagul Fibrinolysis. 2006 Jan;17(1):53-6. doi: 10.1097/01.mbc.0000198991.24222.46. Blood Coagul Fibrinolysis. 2006. PMID: 16607080

8

A new model for predicting the timing of leukapheresis on the basis of CD34+ cell and hematopoietic progenitor cell levels.

Teng HW, Hsiao LT, Chaou SC, Gau JP, Lee TC, Shih YY, Liu CY, Hong YC, Chen MH, Chang MH, Yang YH, Chen PM. Teng HW, et al. Among authors: gau jp. J Clin Apher. 2007;22(4):195-203. doi: 10.1002/jca.20117. J Clin Apher. 2007. PMID: 17294459

9

Complex karyotypes confer a poor survival in adult acute myeloid leukemia with unfavorable cytogenetic abnormalities.

Chen CC, Yang CF, Lee KD, You JY, Yu YB, Ho CH, Tzeng CH, Chau WK, Hsu HC, Gau JP. Chen CC, et al. Among authors: gau jp. Cancer Genet Cytogenet. 2007 Apr 15;174(2):138-46. doi: 10.1016/j.cancergencyto.2006.12.002. Cancer Genet Cytogenet. 2007. PMID: 17452256

10

The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma.

Teng HW, Chen PM, Yang YH, Gau JP. Teng HW, et al. Among authors: gau jp. Jpn J Clin Oncol. 2007 Aug;37(8):609-14. doi: 10.1093/jjco/hym074. Epub 2007 Aug 11. Jpn J Clin Oncol. 2007. PMID: 17693643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page